Today's intrauterine devices (IUDs) are widely available, inexpensive, and safe, but are underused in developed nations because of perceptions that they cause pain and heavy menstrual bleeding, according to an editorial published in the Sept. 1 issue of BMJ.
Today's intrauterine devices (IUDs) are widely available, inexpensive, and safe, but are underused in developed nations because of perceptions that they cause pain and heavy menstrual bleeding, according to an editorial published in the Sept. 1 issue of BMJ.
Sally B. Rose, of the Wellington School of Medicine and Health Sciences at the University of Otago in Wellington, New Zealand, summarized recent research, including a Cochrane review that evaluated data from 15 randomized controlled trials investi gating the effect of nonsteroidal anti-inflammatory drugs for treating or preventing IUD-related pain and bleeding. She said that the review supported the clinical practice of using short courses of such drugs during menses to treat some patients with IUDs.
Although intrauterine devices are the most common form of reversible contraception used worldwide by women of reproductive age, with China alone accounting for nearly 50% of all users, Rose noted that they are used by only 6% of women in the United Kingdom, 4.6% in Australia and New Zealand, and less than 1% in the United States.
Rose SB. Pain and heavy bleeding with intrauterine contraceptive devices. BMJ. 2007;335:410-411.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More